Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 28, Pages 11565-11570
Publisher
Proceedings of the National Academy of Sciences
Online
2013-06-25
DOI
10.1073/pnas.1302114110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
- (2012) Sarah A. Stanley et al. ACS Chemical Biology
- Structure-Guided Discovery of Phenyl-diketo Acids as Potent Inhibitors of M. tuberculosis Malate Synthase
- (2012) Inna V. Krieger et al. CHEMISTRY & BIOLOGY
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Inhibitors of InhA Efficiently KillMycobacterium tuberculosisunder Aerobic and Anaerobic Conditions
- (2011) Catherine Vilchèze et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identifying Vulnerable Pathways in Mycobacterium tuberculosis by Using a Knockdown Approach
- (2011) Paul Carroll et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
- (2011) Kristin N. Adams et al. CELL
- Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: structure–activity relationships
- (2011) Rashmi Tandon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa
- (2010) Thomas R Ioerger et al. BMC GENOMICS
- Screening for In Vitro Antimycobacterial Activity and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Study of 4-(arylamino)coumarin Derivatives
- (2010) Vijay Virsdoia et al. Chemical Biology & Drug Design
- A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase fromMycobacterium tuberculosis
- (2010) Sylvia R. Luckner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
- (2010) Kevin Pethe et al. Nature Communications
- The Dual Function of the Mycobacterium tuberculosis FadD32 Required for Mycolic Acid Biosynthesis
- (2009) Mathieu Léger et al. CHEMISTRY & BIOLOGY
- Pseudomonas aeruginosa Infection of Zebrafish Involves both Host and Pathogen Determinants
- (2009) A. E. Clatworthy et al. INFECTION AND IMMUNITY
- Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis
- (2009) Pooja Arora et al. Nature Chemical Biology
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
- (2009) Subramaniam Ananthan et al. TUBERCULOSIS
- Insights into early mycobacterial pathogenesis from the zebrafish
- (2008) Robin Lesley et al. CURRENT OPINION IN MICROBIOLOGY
- Confronting the scientific obstacles to global control of tuberculosis
- (2008) Douglas B. Young et al. JOURNAL OF CLINICAL INVESTIGATION
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
- (2007) James C. Sacchettini et al. NATURE REVIEWS MICROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started